Golden Entertainment (NASDAQ:GDEN) Upgraded at StockNews.com
StockNews.com raised Golden Entertainment from a “hold” rating to a “buy” rating in a research report on Friday.
Source link
Similar Posts
Trade Deficit Decreased to $52.8 Billion in September
by Calculated Risk on 12/11/2025 08:43:00 AM The Census Bureau and the Bureau of Economic Analysis reported: The U.S. Census Bureau and the U.S. Bureau of Economic Analysis announced today that the goods and services deficit was $52.8 billion in September, down $6.4 billion from $59.3 billion in August, revised. September exports were $289.3 billion,…
Bihar CM Nitish Kumar Provides Rs 456 Crore Flood Relief to 6.51 Lakh Families
August 20, 2025August 20, 2025 Bihar Chief Minister Nitish Kumar transferred more than Rs 456 crore directly into the bank accounts of over 6.51 lakh families. These families were affected by the recent floods on Wednesday. According to the Chief Minister’s Office (CMO), each flood-hit family received Rs 7,000…
CVB – CurveBeam AI Limited
CurveBeam AI is a fully integrated developer and manufacturer of specialised medical imaging (CT) equipment and supporting clinical assessment software aids that, through the use of image analysis, artificial intelligence (AI), and deep learning AI (DLAI), are designed (subject to relevant regulatory clearances being obtained) to automate the analysis of the high-quality images generated on…
Can Robeco: Weaking Internals
Hat Tip: AD Source: Investor Presentation of Canara Robeco Asset Management Company Ltd Source link
It’s Too Soon to Buy the Dip in Weight Loss Drugmakers
Obesity drugmakers like Eli Lilly NYSE: LLY and Novo Nordisk NYSE: NVO were not immune to the broad market sell-off sparked by the June CPI report, but investors looking to get into these names should be cheering. The stocks are down 20% or more from their highs, offering big discounts and the opportunity for fat…
Sakar Healthcare Shares Rally 4% on 9 Cancer Drug Approvals
November 7, 2025November 7, 2025 Shares of Sakar Healthcare Ltd rallied 4% on Friday, 7 November, after the company announced securing marketing approval for 9 drugs. In its regulatory filing, Sakar Healthcare announced securing 9 new marketing approvals for its oncology (cancer) drugs in Europe and emerging regions, increasing…
